MRKR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Marker Therapeutics Inc (MRKR) is not a strong buy for a beginner investor with a long-term strategy and $50,000-$100,000 to invest. The stock lacks positive catalysts, has weak financial performance, and no significant trading signals or news to indicate a compelling entry point. Holding off on this stock is recommended.
The technical indicators are mixed. The MACD is negative and expanding downward, signaling bearish momentum. RSI is neutral at 32.325, not indicating overbought or oversold conditions. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), but the stock is trading below the pivot level of 1.615, with key support at 1.481 and resistance at 1.749.
NULL. No recent news, no significant hedge fund or insider trading trends, and no congress trading data.
Weak financial performance in Q4 2025, with revenue down -51.00% YoY, net income down -55.62% YoY, and EPS down -78.57% YoY. MACD is bearish, and there are no Intellectia Proprietary Trading Signals to support a buy decision.
The company's Q4 2025 financials show significant declines in revenue, net income, and EPS. Revenue dropped to $1,103,444 (-51.00% YoY), net income fell to -$1,703,210 (-55.62% YoY), and EPS decreased to -0.09 (-78.57% YoY). Gross margin remains at 100%, unchanged YoY.
No data on analyst ratings or price target changes.
